Dualitas Therapeutics

South San Francisco, CA · Founded 2023 · Privately Held (backing)

Developer of a bispecific antibody therapeutics platform designed for addressing immunology and inflammation. Dualitas Therapeutics is based in South San Francisco, CA and was founded in 2023. It was valued at $87 million at its early-stage round in Sep 2025, the last priced event on record. It has raised $65 million across 1 recorded round; the latest was a $32.6 million early-stage round in Jul 2025.

PMV mark · valuation
$87.0M
Oct 2026
Priced at
its early-stage round
Sep 2025
Total raised
$65.0M
Last round
Early Stage VC
Jul 2025
What is Dualitas Therapeutics worth?
$87.0MPrivateMarketView mark · Oct 2026

Valued at $87.0M at its early-stage round, Sep 2025. Nothing has traded since.

Free account
More of Dualitas Therapeutics with a free account
  • ·Watch Dualitas Therapeutics: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Valuation timeline

0 priced rounds · 32 daily marks since · Sep 2026 – Oct 2026
▮▮
Markrounds hold their value until the next priced eventMark, today
log scale
Post-money values unlock with a free account.Unlock the axis

Membership and data by Private Market View

Dualitas Therapeutics funding history

1 rounds
DateRoundRaisedPost-money
Jul 2025Early Stage VC$32.6M▮
Unlock post-money valuations

Membership and data by Private Market View

Dualitas Therapeutics valuation

Dualitas Therapeutics was valued at $87 million at its early-stage round in Sep 2025. That is the last priced event on record: no secondary trade or institutional fund mark has moved the figure since.

How much has Dualitas Therapeutics raised?

Dualitas Therapeutics has raised $65 million in total; 1 of its rounds is on record. The largest on record was a $32.6 million early-stage round in Jul 2025.

Dualitas Therapeutics has filed 1 Form D with the SEC, most recently in Nov 2025 ($32.6 million sold to 7 investors).

How Dualitas Therapeutics's valuation is determined

Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.

For Dualitas Therapeutics, the most current credible signal sets the number and the older ones confirm it: a live secondary-market price first, then three or more recent prints, then institutional fund marks, and otherwise the last priced round, which never decays. The valuation is the last round’s post-money moved by the price change since that round, so no share count is assumed. Today it is set by its last priced round. Question about this number? Full methodology →

Frequently asked about Dualitas Therapeutics

What is Dualitas Therapeutics worth?
Dualitas Therapeutics is valued at $87.0M as of Oct 2026. Valued at $87.0M at its early-stage round, Sep 2025. Nothing has traded since.
How much has Dualitas Therapeutics raised?
Dualitas Therapeutics has raised $65.0M in total funding across 1 recorded rounds.
When did Dualitas Therapeutics last raise?
Dualitas Therapeutics last raised in Jul 2025 (Early Stage VC), raising $32.6M.